Timing of Physician Rounds for High-Risk Antepartum Patients
The study investigates how the timing of physician rounds affects the care and outcomes of expectant mothers who are considered high-risk.
Discovery Rounding
+ Standard Rounding
Behavior
+ Communication
Other Study
Summary
Study start date: November 4, 2025
Actual date on which the first participant was enrolled.This research is focused on improving the hospital experience for patients with high-risk pregnancies who are staying in the hospital for a long time. These patients often need frequent visits from doctors, and the study is being conducted at Duke University Hospital. The aim is to find out if changing the timing of doctor visits can make these hospital stays better by improving how patients feel about the communication they have with their healthcare team. By potentially increasing satisfaction with communication, the study hopes to enhance the overall care experience for these patients. Participants in the study will experience one of two types of doctor visit schedules. In the standard schedule, doctors visit patients twice: an early morning visit at the bedside followed by a team discussion later. In the new approach being tested, called "discovery rounding," doctors will visit just once, later in the morning, after the team has reviewed all clinical data. This study is designed to see if having just one later visit makes patients feel better about how information is communicated to them. The research does not mention specific risks or benefits, but it focuses on measuring patient satisfaction with communication as an important outcome.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.200 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Other Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Female
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Inclusion Criteria: * Pregnant women greater than 20 weeks gestation admitted to the antepartum list at Duke University Hospital Exclusion Criteria: * Stillbirth * ICU admission * Admission to off-service unit * Active magnesium sulfate administration * Active severe hypertension or initiation of anti-hypertensive pathway within past 8 hours * Category II fetal heart rate tracing * Other pregnancy/delivery complication precluding delayed rounding * Unstable/unsuitable condition per overnight team or attending physician * Previously enrolled/on active board \>1 day at morning rounds * Postpartum readmission * Antepartum admission within the last 4 weeks
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalGroup II
Active ComparatorStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 2 locations
Duke University Hospital
Durham, United States